Memantine and donepezil hydrochlorides
Memantine and Donepezil Hydrochlorides is a prescription extended-release capsule combining two medications to help manage symptoms of Alzheimer's disease. Donepezil (10 mg) inhibits cholinesterase to improve memory and thinking, while memantine (21 mg) blocks NMDA receptors to protect brain cells. Taken orally once daily, it's manufactured by ANI Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Memantine and Donepezil Hydrochlorides is a prescription extended-release capsule combining two medications to help manage symptoms of Alzheimer's disease. Donepezil (10 mg) inhibits cholinesterase to improve memory and thinking, while memantine (21 mg) blocks NMDA receptors to protect brain cells. Taken orally once daily, it's manufactured by ANI Pharmaceuticals, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Memantine and donepezil hydrochlorides",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Memantine and donepezil hydrochlorides — ANDA 208237 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208237"
}
]
|
| identifier | ANDA208237 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"fda",
"medications",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Memantine and donepezil hydrochlorides |
